Ureteric bud outgrowth in response to RET activation is mediated by phosphatidylinositol 3-kinase.

The c-ret gene encodes a receptor tyrosine kinase (RET) essential for the development of the kidney and enteric nervous system. Activation of RET requires the secreted neurotrophin GDNF (glial cell line-derived neurotrophic factor) and its high affinity receptor, a glycosyl phosphatidylinositol-linked cell surface protein GFRalpha1. In the developing kidney, RET, GDNF, and GFRalpha1 are all required for directed outgrowth and branching morphogenesis of the ureteric bud epithelium. Using MDCK renal epithelial cells as a model system, activation of RET induces cell migration, scattering, and formation of filopodia and lamellipodia. RET-expressing MDCK cells are able to migrate toward a localized source of GDNF. In this report, the intracellular signaling mechanisms regulating RET-dependent migration and chemotaxis are examined. Activation of RET resulted in increased levels of phosphatidylinositol 3-kinase (PI3K) activity and Akt/PKB phosphorylation. This increase in PI3K activity is essential for regulating the GDNF response, since the specific inhibitor, LY294002, blocks migration and chemotaxis of MDCK cells. Using an in vitro organ culture assay, inhibition of PI3K completely blocks the GDNF-dependent outgrowth of ectopic ureter buds. PI3K is also essential for branching morphogenesis once the ureteric bud has invaded the kidney mesenchyme. The data suggest that activation of RET in the ureteric bud epithelium signals through PI3K to control outgrowth and branching morphogenesis.

[1]  I. Fariñas,et al.  GFRα1 Is an Essential Receptor Component for GDNF in the Developing Nervous System and Kidney , 1998, Neuron.

[2]  P. Hawkins,et al.  Activation of the small GTP-binding proteins rho and rac by growth factor receptors. , 1995, Journal of cell science.

[3]  L. Cantley,et al.  HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. , 1995, The American journal of physiology.

[4]  N. Asai,et al.  Rho-dependent and -independent tyrosine phosphorylation of focal adhesion kinase, paxillin and p130Cas mediated by Ret kinase , 1999, Oncogene.

[5]  F. Costantini,et al.  Expression of the c-ret proto-oncogene during mouse embryogenesis. , 1993, Development.

[6]  B. Hogan,et al.  Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. , 2000, The Journal of clinical investigation.

[7]  Frank Costantini,et al.  Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret , 1994, Nature.

[8]  J. Milbrandt,et al.  c-Src Is Required for Glial Cell Line-Derived Neurotrophic Factor (GDNF) Family Ligand-Mediated Neuronal Survival via a Phosphatidylinositol-3 Kinase (PI-3K)-Dependent Pathway , 2001, The Journal of Neuroscience.

[9]  H. Hellmich,et al.  Embryonic expression of glial cell-line derived neurotrophic factor (GDNF) suggests multiple developmental roles in neural differentiation and epithelial-mesenchymal interactions , 1996, Mechanisms of Development.

[10]  M. Saarma,et al.  Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. , 1997, Development.

[11]  G. Dressler,et al.  Differential expression and function of cadherin-6 during renal epithelium development. , 1998, Development.

[12]  J. Bard,et al.  8 The Development of the Kidney , 1998, Current Topics in Developmental Biology.

[13]  Jonas Frisén,et al.  Renal agenesis and the absence of enteric neurons in mice lacking GDNF , 1996, Nature.

[14]  J. Louis,et al.  GDNF–Induced Activation of the Ret Protein Tyrosine Kinase Is Mediated by GDNFR-α, a Novel Receptor for GDNF , 1996, Cell.

[15]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[16]  M. Santoro,et al.  Docking Protein FRS2 Links the Protein Tyrosine Kinase RET and Its Oncogenic Forms with the Mitogen-Activated Protein Kinase Signaling Cascade , 2001, Molecular and Cellular Biology.

[17]  M. Borrello,et al.  Identification of Shc docking site on Ret tyrosine kinase , 1997, Oncogene.

[18]  G. Paratcha,et al.  Released GFRα1 Potentiates Downstream Signaling, Neuronal Survival, and Differentiation via a Novel Mechanism of Recruitment of c-Ret to Lipid Rafts , 2001, Neuron.

[19]  F. Grigorescu,et al.  Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling. , 1994, The EMBO journal.

[20]  L. Cantley,et al.  Phosphoinositide kinases. , 1998, Annual review of biochemistry.

[21]  Mart Saarma,et al.  Defects in enteric innervation and kidney development in mice lacking GDNF , 1996, Nature.

[22]  M. Borrello,et al.  The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma , 1996, Molecular and cellular biology.

[23]  G. Dressler,et al.  Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. , 2001, Development.

[24]  J. Cooper.  The role of actin polymerization in cell motility. , 1991, Annual review of physiology.

[25]  Ming-Jer Tang,et al.  The RET–Glial Cell-derived Neurotrophic Factor (GDNF) Pathway Stimulates Migration and Chemoattraction of Epithelial Cells , 1998, The Journal of cell biology.

[26]  J. Downward,et al.  Phosphoinositide 3-Kinase Induces Scattering and Tubulogenesis in Epithelial Cells through a Novel Pathway* , 1998, The Journal of Biological Chemistry.

[27]  G. Dressler,et al.  The molecular basis of embryonic kidney development , 1997, Mechanisms of Development.

[28]  B. Ponder,et al.  Mutations of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.

[29]  P. Comoglio,et al.  Regulation of scatter factor/hepatocyte growth factor responses by Ras, Rac, and Rho in MDCK cells , 1995, Molecular and cellular biology.

[30]  C. Worby,et al.  Glial cell line-derived neurotrophic factor activates the receptor tyrosine kinase RET and promotes kidney morphogenesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Susan S. Taylor,et al.  Shc and Enigma Are Both Required for Mitogenic Signaling by Ret/ptc2 , 1998, Molecular and Cellular Biology.

[32]  al. et,et al.  Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B , 1995, Science.

[33]  Susan S. Taylor,et al.  Tyrosines outside the Kinase Core and Dimerization Are Required for the Mitogenic Activity of RET/ptc2 (*) , 1995, The Journal of Biological Chemistry.

[34]  V. D’Agati,et al.  Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. , 1996, Development.

[35]  P. Goodfellow,et al.  Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  I. Fariñas,et al.  Renal and neuronal abnormalities in mice lacking GDNF , 1996, Nature.

[37]  G. D. Vita,et al.  The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret , 2001, Oncogene.

[38]  J. Davies,et al.  Erk MAP kinase regulates branching morphogenesis in the developing mouse kidney. , 2001, Development.

[39]  R. Scott,et al.  Signaling Complexes and Protein-Protein Interactions Involved in the Activation of the Ras and Phosphatidylinositol 3-Kinase Pathways by the c-Ret Receptor Tyrosine Kinase* , 2000, The Journal of Biological Chemistry.

[40]  R. A. Decker,et al.  Oncogenic RET Receptors Display Different Autophosphorylation Sites and Substrate Binding Specificities (*) , 1996, The Journal of Biological Chemistry.

[41]  B. Ponder,et al.  Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A , 1993, Nature.

[42]  Susan S. Taylor,et al.  Mitogenic Signaling by Ret/ptc2 Requires Association with Enigma via a LIM Domain* , 1996, The Journal of Biological Chemistry.

[43]  R. Hofstra,et al.  A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma , 1994, Nature.

[44]  M. Kasuga,et al.  Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling , 1994, Current Biology.

[45]  B. Pasini,et al.  Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease , 1994, Nature.

[46]  M. Billaud,et al.  Transforming Ability of MEN2A-RET Requires Activation of the Phosphatidylinositol 3-Kinase/AKT Signaling Pathway* , 2000, The Journal of Biological Chemistry.